Puma Biotechnology
PBYI
PBYI
156 hedge funds and large institutions have $1.64B invested in Puma Biotechnology in 2018 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 61 increasing their positions, 46 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
10% less funds holding
Funds holding: 174 → 156 (-18)
23% less capital invested
Capital invested by funds: $2.13B → $1.64B (-$486M)
44% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 39
Holders
156
Holding in Top 10
1
Calls
$35.4M
Puts
$32.9M
Top Buyers
| 1 | +$34.4M | |
| 2 | +$23.7M | |
| 3 | +$18.8M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$14.5M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$12.7M |
Top Sellers
| 1 | -$53M | |
| 2 | -$27.7M | |
| 3 | -$24.5M | |
| 4 |
Jennison Associates
New York
|
-$21.2M |
| 5 |
TCP
Tourbillon Capital Partners
New York
|
-$15.7M |